Molecular and Cellular Biology, December 2009, p. 6321-6334, Vol. 29, No. 23
0270-7306/09/$08.00+0 doi:10.1128/MCB.00103-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
into the Plexin-B1 Receptor Complex 
Institute of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, D-69120 Heidelberg, Germany,1 Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Parkstr. 1, D-61231 Bad Nauheim, Germany2
Received 22 January 2009/ Returned for modification 3 April 2009/ Accepted 18 September 2009
The semaphorin 4D (Sema4D) receptor plexin-B1 constitutively interacts with particular Rho guanine nucleotide exchange factors (RhoGEFs) and thereby mediates Sema4D-induced RhoA activation, a process which involves the tyrosine phosphorylation of plexin-B1 by ErbB-2. It is, however, unknown how plexin-B1 phosphorylation regulates RhoGEF activity. We show here that activation of plexin-B1 by Sema4D and its subsequent tyrosine phosphorylation creates docking sites for the SH2 domains of phospholipase C
(PLC
). PLC
is thereby recruited into the plexin-B1 receptor complex and via its SH3 domain activates the Rho guanine nucleotide exchange factor PDZ-RhoGEF. PLC
-dependent RhoGEF activation is independent of its lipase activity. The recruitment of PLC
has no effect on the R-Ras GTPase-activating protein activity of plexin-B1 but is required for Sema4D-induced axonal growth cone collapse as well as for the promigratory effects of Sema4D on cancer cells. These data demonstrate a novel nonenzymatic function of PLC
as an important mechanism of plexin-mediated signaling which links tyrosine phosphorylation of plexin-B1 to the regulation of a RhoGEF protein and downstream cellular processes.
Published ahead of print on 5 October 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»